Emmaus Life Sciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Emmaus Life Sciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q4 2024.
  • Emmaus Life Sciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 18, 2024 was 63.9M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 63.9M Nov 18, 2024 10-Q 2024-11-19
Q3 2024 63.9M +10.2M +19.1% Aug 15, 2024 10-Q 2024-09-10
Q2 2024 63.9M +10.2M +19.1% Aug 12, 2024 10-Q 2024-09-10
Q1 2024 61.8M +10.9M +21.4% Mar 31, 2024 10-K 2024-07-03
Q3 2023 53.6M +4.08M +8.23% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 53.6M +4.08M +8.23% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 50.9M +1.62M +3.29% Mar 15, 2023 10-K 2023-03-31
Q3 2022 49.6M +247K +0.5% Nov 10, 2022 10-Q 2022-11-14
Q2 2022 49.6M +247K +0.5% Aug 10, 2022 10-Q 2022-08-15
Q1 2022 49.3M 0 0% Mar 15, 2022 10-K 2022-03-31
Q3 2021 49.3M Aug 24, 2021 10-Q 2021-09-01
Q2 2021 49.3M Jul 14, 2021 10-K/A 2022-07-01
Q1 2021 49.3M Apr 5, 2021 10-K 2021-05-04
Q4 2020 49M Jan 5, 2021 10-K 2021-01-25
Q3 2019 48.5M Nov 11, 2019 10-Q 2019-11-13
Q2 2019 47.5M +41.2M +655% Aug 14, 2019 10-Q 2019-08-14
Q1 2019 9.48M +5.12M +117% May 10, 2019 10-Q 2019-05-13
Q4 2018 7.56M +3.19M +73.3% Dec 10, 2018 10-K 2018-12-11
Q2 2018 6.28M +2.05M +48.2% Aug 10, 2018 10-Q 2018-08-10
Q1 2018 4.36M +1.83M +72.2% Feb 20, 2018 10-Q 2018-02-20
Q4 2017 4.36M +2.13M +95.6% Dec 29, 2017 10-K 2017-12-29
Q2 2017 4.24M Aug 14, 2017 10-Q 2017-08-14
Q1 2017 2.53M -105M -97.6% May 15, 2017 10-Q 2017-05-15
Q4 2016 2.23M -100M -97.8% Dec 21, 2016 10-K 2016-12-22
Q3 2016 107M Aug 15, 2016 10-Q 2016-08-15
Q1 2016 107M +5.8M +5.71% May 13, 2016 10-Q 2016-05-16
Q4 2015 102M +750K +0.74% Jan 4, 2016 10-K 2016-01-05
Q2 2015 102M 0 0% Aug 14, 2015 10-Q 2015-08-14
Q1 2015 102M +1.12M +1.11% May 15, 2015 10-Q/A 2015-05-18
Q4 2014 102M +5.6M +5.83% Dec 29, 2014 10-K 2014-12-29
Q2 2014 102M +20.5M +25.3% Aug 13, 2014 10-Q 2014-08-14
Q1 2014 101M +62.2M +162% May 14, 2014 10-Q 2014-05-15
Q4 2013 96.1M +94M +4518% Dec 20, 2013 10-K 2013-12-23
Q2 2013 81.1M +79.3M +4229% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 38.4M +36.5M +1948% May 14, 2013 10-Q 2013-05-15
Q4 2012 2.08M -54.1M -96.3% Jan 14, 2013 10-K 2013-01-15
Q2 2012 1.87M Aug 13, 2012 10-Q/A 2012-09-11
Q1 2012 1.87M May 14, 2012 10-Q 2012-05-15
Q4 2011 56.2M Feb 13, 2012 10-Q 2012-02-14
Q3 2011 56.1M Aug 15, 2011 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.